-
TOMORROW, Treatment of KRAS Mutated Non-Small Cell Lung Cancer MOASC News/MOASC Programs
-
THIS SATURDAY! Spotlight On Hematology MOASC News/MOASC Programs
-
Employers required to pay 80 hours of supplemental paid sick. California News
-
FTC voted not to study PBM anti-competitive behavior. National News
|
|
MOASC Programs - Save the Dates - All Times are Pacific
|
|
TOMORROW! February 23, 2022, MOASC presents their Lung Cancer Series webinar on the Treatment of KRAS Mutated Non-Small Cell Lung Cancer. Join Hatim Husain, MD, University of California San Diego, Jonathan Riess, M.D., University of California, Davis, and Sukhmani Padda, M.D., Cedars-Sinai Medical Center for a lively discussion. This is a great opportunity to learn from key opinion leaders and network with colleagues. Hear the latest clinical trial data, apply it to your patients, consider real-world scenarios and how to mitigate barriers to treatment. Submit your questions and cases, in advance, for collaborative discussion with colleagues and experts.
|
|
February 26, 2022, MOASC presents Spotlight On Hematology. Selected fellows and faculty, from the University of California, Irvine, will present the premier topics from their attendance at the 2021 Annual ASH Meeting. Through virtual conferencing, the presentations will promote collegial discourse among colleagues and networking among attendees.
|
|
March 26, 2022 - MOASC’s 7th Annual Oncology Summit & Research Symposium at the Hyatt Regency in Huntington Beach. This LIVE Meeting will follow a multi-tumor approach with nationally recognized speakers, which will review personalized cancer care and current clinical trials in Breast, Gastrointestinal, Genitourinary, Lung, CAR-T/Transplant and Myeloma. This will be a great opportunity to learn from experts and network with colleagues.
|
|
The Hoag Oncology Nursing Conference is virtual again this year. Word is, it is simply the best virtual oncology nursing event!
March 11-12, 2022 Hoag Oncology Nursing Conference
April 27 – May 1, 2022 Oncology Nursing Congress
|
|
UC San Diego invites you to an interactive online learning experience on Gather-ed where you can earn free CME credits and learn about Advances in Basal Cell Carcinoma at your own pace from your own computer. We think you will find it enjoyable, and the time commitment is extremely modest and flexible.
|
|
You are cordially invited to a CME/CNE-certified, ABIM MOC-eligible, live webinar entitled, Personalized Approaches to HER2-Positive Breast Cancer Treatment, Thursday, April 21, 2022, 5:30 PM – 6:30 PM Pacific. This activity will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.
|
|
Career News
PRACTICE OPERATIONS MANAGER NEEDED. Ventura County Hematology Oncology Specialists is seeking a dynamic individual to efficiently manage the day-to-day operations of its 3-location group practice.
Requirements: Bachelor’s degree with medical office management experience or an associate degree with at least 5 years of healthcare management experience. Exceptional communication skills and the ability to facilitate a culture of growth, collaboration and professionalism. Excellent computer skills and previous knowledge of EMR.
Sign up now to receive the MOASC Job Flash™! Please activate your new job alert.
|
|
MOASC Clinical Trial Database is on the MOASC website at www.moasc.org
|
|
The California State Assembly passed a new version of Supplemental Paid Sick Leave (SPSL) Bill (AB) 84 that took effect on February 19, 2022, and apply retroactively back to January 1, 2022. The law expires September 30, 2022. FAQs should be available soon on the Labor Commissioner’s webpage. The law applies to employers with 26 or more employees to provide up to 80 hours of supplemental paid sick leave for qualifying COVID-19 related reasons.
|
|
A bill from Senator Limon, SB912, calls for biomarker testing coverage. This bill is sponsored by the ACS CAN and University of California.
|
|
SB 853, Prescription drug coverage. A health care service plan contract that covers prescription drug benefits shall not be issued, amended, delivered, or renewed in this state if the plan limits or excludes coverage for a drug or dose of a drug on the basis that the drug or dose of the drug is prescribed for a use or dosage level that is line 8 different from the use or dosage level for which that drug has been line 9 approved for marketing by the federal Food and Drug line 10 Administration (FDA), provided that all of the following conditions line 11 have been met.
|
|
Billing and Coding: JW Modifier Billing Guidelines - R2 - Effective April 28, 2020
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
|
|
January 2022 Add-On Codes Incorrect Denials Alert
Thirty-eight procedure codes are denying incorrectly due to changes with the January 2022 release.
|
|
Incorrect Coinsurance Percentage Applied for Drugs and Biologicals Alert
The MCS system is calculating the copayment amount for drugs and biologicals incorrectly.
|
|
February 23, 2022 2022 - CMS Evaluation and Management Regulation Modifications
This webinar will include split/shared visits involving a physician and nonphysician practitioner, critical care services in the post-op period that are unrelated to the surgery, services furnished by teaching physicians involving residents, and updates to telehealth. You will learn why policies were refined, how to apply the new modifiers for E/M codes, and what should be documented to support them. This session will include a question and answer segment.
|
|
February 24, 2022. Please go to the link below to review the notice regarding an Open Public Meeting. One of the several policies being discussed is MolDX: Plasma-Based Genomic Profiling in Solid Tumors; Epidural Steroid Injections for Pain Management. This meeting will be held via teleconference only from 10:00am-1:00pm Pacific time.
|
|
All pharmacy providers, regardless of setting or specialty, are encouraged to submit comment to CMS on DIR Fees and the broken PBM rebate system before they close on March 7, 2022. CMS is currently proposing to regulate DIR Fees and ensure that all price concessions are passed on to patients at the point of sale.
|
|
CMS announced a national coverage determination that expands coverage for lung cancer screening with low dose computed tomography (LDCT) to improve health outcomes for people with lung cancer. This final decision expands eligibility for people with Medicare to get lung cancer screening with LCDT by: Lowering the starting age for screening from 55 to 50 years and Reducing the tobacco smoking history from at least 30 packs per year to at least 20 packs per year.
|
|
On February 17, 2022, U.S. Federal Trade Commission (FTC) voted not to study PBM anti-competitive behavior. COA commissioned a report providing a most detailed compilation, to date, of abusive and anti-competitive PBM strategies. The report recommends legal and policy solutions. |
|
Eight years ago, AIR340B first started analyzing charity care levels provided by 340B DSH hospitals. This new report highlights the extent to which the unchecked growth, lax oversight, and lack of transparency of 340B entities continue to destabilize the program. Read AIR340B’s new report, “Left Behind: An Analysis of Charity Care Provided by Hospitals Enrolled in the 340B Drug Pricing Program.”
|
|
The Senate, last week, narrowly confirmed Dr. Robert Califf as commissioner of the Food and Drug Administration, a key federal agency that has been without a permanent chief for more than a yearlong stretch of the coronavirus pandemic. The vote was 50-to-46, with six Republicans crossing the aisle to support him while five senators who caucus with Democrats opposed him. One senator voted present. With a permanent political leader in place after a 13-month holding pattern, the agency will be more empowered to move forward with sensitive policies and accelerate its regulatory agenda.
The bi-partisan legislation, Dr. Lorna Breen Health Care Provider Protection Act, passed through the United States Congress and now awaits President Biden’s signature. The
Act will provide much needed support to help prevent physician suicide and burnout, as well as improve resources to reduce the barriers that currently hinder physicians and other health care professionals to seek mental health support.
|
|
Oncology ranks 26th of 29 specialties surveyed with 36 percent of oncologists reporting burnout. Emergency medicine physicians have the highest rates of burnout among all physician specialties at 60% and the lowest is Public health and preventive medicine at 26 percent, according to a Medscape's 2022 Physician Burnout and Depression report. More than 13,000 physicians across 29 specialties were surveyed between June 29 and Sept. 26, 2021. Across all specialties, 47 percent reported feeling burned out last year.
|
|
Affiliate Association News |
|
March 11-13, 2022, the 22nd Multidisciplinary Management of Cancers: A Case-based Approach returns to the Silverado Resort and Spa in Napa. The meeting is sponsored by the Association of Northern California Oncologists, Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and the UCSF Helen Diller Family Comprehensive Cancer Center. Registration is now open for HCP for in person and virtual attendance.
|
|
ASCO and the American Cancer Society (ACS) initiated a collaboration on February 1 to ensure that people can easily find the trusted, expert-approved cancer content they need when turning to either organization for information. As an initial step, the organizations are cross-sharing select cancer prevention, screening, and survivorship resources on their patient and consumer education websites, Cancer.Net and Cancer.org.
|
|
Monday, February 28, 2022, ASH presents Targeted Treatment: Choose Wisely and Use of MRD. The ASH Academy on Demand is your one-stop shop for free educational resources in hematology. Attend live webinars presented by leading industry experts, access recorded materials, engage in test simulations and self-assessments, and join our virtual classrooms – all at your own convenience; no membership required.
|
|
ASH has well-established mentorship programs and an outstanding record in supporting hematology professionals at every career stage. Applications for the 2022 Medical Educators Institute are open for submission through May 6. For the first time this year, ASH is offering application mentors for diverse and underrepresented groups in hematology, medical education, and the MEI program.
|
|
COA is seeking more evidence of practices receiving faxes from CVS/Caremark regarding “patient request” to fill prescriptions for drug already provided in the physician office. The patients have not requested that their prescriptions be sent to CVS, contrary to what the fax states, and causes patient confusion. COA is interested in your similar experience of PBM interference in the physician-patient relationship and treatment. Please send your information to
Ricky Newton, CPA, Chief Financial and Operating Officer, Community Oncology Alliance (COA), rnewton@coacancer.org
|
|
The 2022 Community Oncology Conference is two days, but the agenda is packed with all the information you need to know to beat challenges in the coming year. At this year’s Conference, learn about the needs of community oncology practices in the future and how you can incorporate these lessons into your own practice. Learn to address socioeconomic, racial, and ethnic differences, which greatly affect how care is provided and outcomes. Hear how practices work to address these problems. On March 17-18, oncology professionals from around the country will gather at the Gaylord Palms Hotel in Kissimmee, Florida for the best oncology conference in the country.
|
|
CURE’s sister franchise, Physician’s Education Resource (PER) has an upcoming CME opportunity. As MOASC is a partner, PER is offering 35% discounted registration for MOASC physicians to the 39th Annual Miami Breast Cancer Conference, March 3-6, 2022 at the Fontainebleau Miami Beach, Miami Beach, FL. This event will be Live, In-person & Virtual
Program chairs: Patrick L. Borden, MD, Debu Tripathy, MD, Hope S. Rugo, MD, FASCO.
|
|
The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care. The material contained in the California Oncology Weekly is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the California Oncology Weekly may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in California Oncology Weekly should not be used as a substitute for such advice. This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein. CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.
|
|
|
|
|
|
|
